The relative importance of actual and potential competition: Empirical evidence from the pharmaceuticals market

Journal of Industrial Economics

Volumn 51, Issue 4, 2003, Pages 455-467

  Bergman, Mats A ^a,b   Rudholm, Niklas ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347577796     PISSN: 00221821     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-1821.2003.00210.x     Document Type: Article

References (26)

1. Aronsson, T., Bergman, M. A. and Rudholm, N., (2001), 'The Impact of Generic Competition on Brand Name Market Shares - Evidence from Micro Data,' Review of Industrial Organization, 19, 423-433.
2. Bain, J., (1949), 'A Note on Pricing in Monopoly and Oligopoly,' American Economic Review, 39, 448-464.
3. Baumol, William J., Panzar, John C. and Willig, Robert D., (1982), Contestable Markets and the Theory of Industry Structure (Harcourt Brace Jovanovich, New York).
4. Bergman, M. A., (2002), Potential Competition: Theory, Empirical Evidence, and Legal Practice, working paper, Swedish Competition Authority, Stockholm, available at www.kkv.se/eng_indexns.htm.
5. Caves, R. E., Whinston, M. D. and Hurwitz, M. A., (1991), 'Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry', Brookings Papers on Economic Activity: Microeconomics, Brookings Institution, Washington D.C.
6. Cool, K., Röller, L.-H. and Leleux, B., (1999), 'The Relative Impact of Actual and Potential Rivalry on Firm-Profitability in the Pharmaceutical Industry,' Strategic Management Journal, 20, 1-14.
7. Davidsson, R. and MacKinnon, J., (1981), 'Several Tests for Model Specification in the Presence of Alternative Hypotheses,' Econometrica, 49, 781-793.
8. Dixit, A., (1982), 'The Role of Investment in Entry Deterrence,' Economic Journal, 90, 95-106.
9. Ekelund, M., (2000), 'Generic Entry Before and After Reference Prices,' mimeo, Stockholm School of Economics, 2000.
10. Ellison, G. and Ellison, S. F., (2000), 'Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration,' mimeo, (MIT, Cambridge).
11. Ferrándiz, J. M., (1999), 'The Impact of Generic Goods in the Pharmaceutical Industry,' Health Economics, 8, 599-612.
12. Frank, R. G. and Salkever, D. S., (1992), 'Pricing, Patent Loss and the Market for Pharmaceuticals,' Southern Economic Journal, 59, 165-179.
13. Gilbert, R., (1989), 'The Role of Potential Competition in Industrial Organization,' Journal of Economic Perspectives, 3, 107-127.
14. McAleer, M., Fisher, G. and Volker, P., (1982), 'Separate Misspecified Regressions and the U.S. Long-Run Demand for Money Function,' Review of Economics and Statistics, 64, 572-583.
15. Milgrom, P. and Roberts, J., (1982), 'Limit Pricing and Entry Under Incomplete Information: An Equilibrium Analysis,' Econometrica, 50, 443-459.
16. Modigliani, F., (1958), 'New Developments on the Oligopoly Front,' Journal of Political Economy, 66, 215-232.
17. Morrison, Steven A. and Winston, C., (1987), 'Empirical Implications and Tests of the Contestability Hypothesis,' Journal of Law and Economics, 30, 53-66.
18. Newey, W. and West, K., (1987), 'A Simple, Positive Semi-Definite, Heteroskedasticity and Autocorrelation Consistent Covariance Matrix,' Econometrica, 55, 703-708.
19. RFFS 1992:20 'Riksförsäkringsverkets föreskrifter om fastställande av pris på läkemedel.'
20. RFFS 1996:31 'Riksförsäkringsverkets föreskrifter om fastställande av pris på läkemedel.'
21. Rudholm, N., (2001), 'Entry and the Number of Firms in the Swedish Pharmaceuticals Market,' Review of Industrial Organization, 19, 351-364.
22. Scott Morton, F. M., (1999), 'Entry Decisions in the Generic Pharmaceutical Industry,' Rand Journal of Economics, 30, 421-440.
23. SFS 1981:49 'Lag om begränsning av läkemedelskostnader, m.m.'
24. Spence, A. M., (1977), 'Entry, Capacity, Investment, and Oligopoly Pricing,' Bell Journal of Economics, 8, 534-544.
25. Suh, D-C, Schondelmeyer, S. W., Manning, W. G. Jr., Hadsall, R. S. and Nyman, J. A., (1999), 'Price Trends Before and After Patent Expiration in the Pharmaceutical Industry,' Journal of Research in Pharmaceutical Economics, 9, 17-32.
26. Sylos-Labini, P., (1962), Oligopoly and Technical Progress (Harvard University Press, Cambridge, Mass).